Nancy Devlin : Citation Profile

Are you Nancy Devlin?

University of Melbourne (47% share)
University of Sheffield (47% share)
Office of Health Economics (6% share)

15

H index

19

i10 index

758

Citations

RESEARCH PRODUCTION:

70

Articles

8

Papers

4

Books

RESEARCH ACTIVITY:

   28 years (1994 - 2022). See details.
   Cites by year: 27
   Journals where Nancy Devlin has often published
   Relations with other researchers
   Recent citing documents: 52.    Total self citations: 38 (4.77 %)

MORE DETAILS IN:
ABOUT THIS REPORT:

   Permalink: http://citec.repec.org/pde347
   Updated: 2024-07-05    RAS profile: 2022-11-06    
   Missing citations? Add them    Incorrect content? Let us know

Relations with other researchers

Works with:

Shah, Koonal (4)

Lancsar, Emily (3)

Authors registered in RePEc who have co-authored more than one work in the last five years with Nancy Devlin.

Is cited by:

Attema, Arthur (27)

Brouwer, Werner (23)

Gutacker, Nils (14)

Siciliani, Luigi (13)

Brazier, John (13)

Street, Andrew (10)

Blankart, Katharina (10)

Tsuchiya, Aki (10)

Claxton, Karl (9)

Viney, Rosalie (8)

Gu, Yuanyuan (7)

Cites to:

Shah, Koonal (30)

Brazier, John (28)

Tsuchiya, Aki (24)

Parkin, David (21)

Roberts, Jennifer (14)

Street, Andrew (9)

Feng, Yan (9)

Brouwer, Werner (8)

Culyer, Anthony (8)

McCabe, Christopher (7)

Rice, Nigel (7)

Main data

Where Nancy Devlin has published?

Journals with more than one article published# docs
Health Economics16
PharmacoEconomics15
The European Journal of Health Economics12
Health Policy6
Applied Health Economics and Health Policy5
Medical Decision Making4
Social Science & Medicine4
PharmacoEconomics - Open2
The Patient: Patient-Centered Outcomes Research2

Working Papers Series with more than one paper published# docs
Working Papers / Centre for Health Economics, University of York5
Monograph / Office of Health Economics4

Recent works citing Nancy Devlin (2024 and 2023)

YearTitle of citing document
2024Whats in a Bill? A Model of Imperfect Moral Hazard in Healthcare. (2022). Zhu, ED ; Anderson, David M ; Hoagland, Alex. In: Papers. RePEc:arx:papers:2211.01116.

Full description at Econpapers || Download paper

2023Using Limited Trial Evidence to Credibly Choose Treatment Dosage when Efficacy and Adverse Effects Weakly Increase with Dose. (2023). Manski, Charles F. In: Papers. RePEc:arx:papers:2305.17206.

Full description at Econpapers || Download paper

2023The use of patient-reported outcome and experience measures for health policy purposes: A scoping review in oncology. (2023). Ferrua, M ; Fourcade, A ; Fierobe, A ; Minvielle, E ; Mir, O ; Scotte, F ; di Palma, M. In: Health Policy. RePEc:eee:hepoli:v:129:y:2023:i:c:s0168851022003165.

Full description at Econpapers || Download paper

2023The functions of known to be inaccurate prices in markets: A cross-country comparison of pharmaceutical list pricing. (2023). Krafve, Linus Johansson ; Sjogren, Ebba ; Kjellberg, Hans. In: Journal of Business Research. RePEc:eee:jbrese:v:167:y:2023:i:c:s0148296323005520.

Full description at Econpapers || Download paper

2023Barriers and facilitators to implementing priority setting and resource allocation tools in hospital decisions: A systematic review. (2023). Cutler, Henry ; Gu, Yuanyuan ; Seil, Elizabeth ; Bilgrami, Anam ; Jeet, Varinder ; Ahumada-Canale, Antonio. In: Social Science & Medicine. RePEc:eee:socmed:v:322:y:2023:i:c:s0277953623001478.

Full description at Econpapers || Download paper

2023Randomised comparison of online interviews versus face-to-face interviews to value health states. (2023). Dalziel, Kim ; Yang, Yaling ; Rowen, Donna ; Devlin, Nancy ; Bourke, Mackenzie ; Peasgood, Tessa. In: Social Science & Medicine. RePEc:eee:socmed:v:323:y:2023:i:c:s0277953623001752.

Full description at Econpapers || Download paper

2023Derivation of a UK preference-based value set for the Short Warwick-Edinburgh Mental Well-being Scale (SWEMWBS) to allow estimation of Mental Well-being Adjusted Life Years (MWALYs). (2023). Madan, Jason ; Stewart-Brown, Sarah ; Petrou, Stavros ; Buckell, John ; Edmund, Hei Hang. In: Social Science & Medicine. RePEc:eee:socmed:v:327:y:2023:i:c:s027795362300285x.

Full description at Econpapers || Download paper

2023Algorithms and heuristics of health technology assessments: A retrospective analysis of factors associated with HTA outcomes for new drugs across seven OECD countries. (2023). Gentilini, Arianna ; Visintin, Erica ; Kanavos, Panos. In: Social Science & Medicine. RePEc:eee:socmed:v:331:y:2023:i:c:s0277953623004021.

Full description at Econpapers || Download paper

2023Valuing indigenous quality of life: A review of preference-based quality of life instruments and elicitation techniques with global older indigenous populations. (2023). Bessarab, Dawn ; Ratcliffe, Julie ; Taylor, Kevin ; Smith, Kate. In: Social Science & Medicine. RePEc:eee:socmed:v:336:y:2023:i:c:s0277953623006287.

Full description at Econpapers || Download paper

2023A structured methodology for essential medicines lists and health emergency stockpiles: Experience with the Emergency Medicines Buffer Stock in the United Kingdom. (2023). Kanavos, P ; Montibeller, G ; Angelis, A. In: Social Science & Medicine. RePEc:eee:socmed:v:337:y:2023:i:c:s0277953623005932.

Full description at Econpapers || Download paper

2023“Its not a one operation fits all”: A qualitative study exploring fee setting and participation in price transparency initiatives amongst medical specialists in the Australian private healthcare secto. (2023). Mendez, Susan ; la Brooy, Camille ; Sabanovic, Hana ; Prang, Khic-Houy ; Elshaug, Adam G ; Scott, Anthony ; Yong, Jongsay. In: Social Science & Medicine. RePEc:eee:socmed:v:339:y:2023:i:c:s0277953623007104.

Full description at Econpapers || Download paper

2024Understanding UK public views on normative decisions made to value health-related quality of life in children: A qualitative study. (2024). Keetharuth, Anju ; Rowen, Donna ; Powell, Philip A ; Mukuria, Clara. In: Social Science & Medicine. RePEc:eee:socmed:v:340:y:2024:i:c:s0277953623008638.

Full description at Econpapers || Download paper

2023Identifying the value of a clinical information system during the COVID-19 pandemic. (2023). Jones, Paul ; Madhavan, Naveen. In: Technovation. RePEc:eee:techno:v:120:y:2023:i:c:s0166497221002273.

Full description at Econpapers || Download paper

2023Making an economic argument for investment in global mental health: the case of conflict-affected refugees and displaced people. (2023). Park, A-La ; McDaid, David. In: LSE Research Online Documents on Economics. RePEc:ehl:lserod:118149.

Full description at Econpapers || Download paper

2023Open and inclusive: fair processes for financing universal health coverage. (2023). Kurowski, Christoph. In: LSE Research Online Documents on Economics. RePEc:ehl:lserod:119795.

Full description at Econpapers || Download paper

2023.

Full description at Econpapers || Download paper

2023.

Full description at Econpapers || Download paper

2023.

Full description at Econpapers || Download paper

2023.

Full description at Econpapers || Download paper

2023.

Full description at Econpapers || Download paper

2024.

Full description at Econpapers || Download paper

2023.

Full description at Econpapers || Download paper

2023National Quality and Sustainable Development: An Empirical Analysis Based on China’s Provincial Panel Data. (2023). Wang, Yu Kun ; Liu, Duochenxi ; You, Shibing. In: Sustainability. RePEc:gam:jsusta:v:15:y:2023:i:6:p:4879-:d:1092320.

Full description at Econpapers || Download paper

2023Effect of price transparency on the perception of fair price and satisfaction with the purchase of sports products. (2023). Aghaei, Malihe Sadat ; Mirzazadeh, Zahra Sadat ; Sepehrian, Amir Hossein. In: Journal of Revenue and Pricing Management. RePEc:pal:jorapm:v:22:y:2023:i:5:d:10.1057_s41272-022-00391-w.

Full description at Econpapers || Download paper

2024Economic Evaluation under Ambiguity and Structural Uncertainties. (2023). Andrews, Brendon. In: Working Papers. RePEc:ris:albaec:2023_009.

Full description at Econpapers || Download paper

2024Health Expenditure and Economic Growth Nexus: Empirical Evidence from South Asian Countries. (2024). Das, Aurolipsa ; Mohanty, Saileja ; Sethi, Narayan ; Sahoo, Malayaranjan. In: Global Business Review. RePEc:sae:globus:v:25:y:2024:i:2_suppl:p:s229-s243.

Full description at Econpapers || Download paper

2024Testing Nonmonotonicity in Health Preferences. (2024). Sanchez Martinez, Fernando Ignacio ; Sanchez-Martinez, Fernando-Ignacio ; Abellan-Perpian, Jose-Maria ; Martinez-Perez, Jorge-Eduardo ; Pinto-Prades, Jose-Luis. In: Medical Decision Making. RePEc:sae:medema:v:44:y:2024:i:1:p:42-52.

Full description at Econpapers || Download paper

2023Comparing EQ-5D-3L and EQ-5D-5L in measuring the HRQoL burden of 4 health conditions in China. (2023). Li, Sha ; Yang, Zhihao ; Jiang, Jie ; Mukuria, Clara ; Luo, Nan ; Hong, Yanming ; Weng, Guizhi. In: The European Journal of Health Economics. RePEc:spr:eujhec:v:24:y:2023:i:2:d:10.1007_s10198-022-01465-7.

Full description at Econpapers || Download paper

2023Time and lexicographic preferences in the valuation of EQ-5D-Y with time trade-off methodology. (2023). Attema, Arthur ; Shah, Koonal K ; Zhang, Liying ; Lipman, Stefan A. In: The European Journal of Health Economics. RePEc:spr:eujhec:v:24:y:2023:i:2:d:10.1007_s10198-022-01466-6.

Full description at Econpapers || Download paper

2023A hearing bolt-on item increased the measurement properties of the EQ-5D-5L in a community-based hearing loss screening program. (2023). Luo, Nan ; Tan, Rachel Lee-Yin ; Chong, Sheue-Lih ; Wang, Pei. In: The European Journal of Health Economics. RePEc:spr:eujhec:v:24:y:2023:i:3:d:10.1007_s10198-022-01479-1.

Full description at Econpapers || Download paper

2023Completing the time trade-off with respondents who are older, in poorer health or with an immigrant background in an EQ-5D-5L valuation study. (2023). Rand, Kim ; Stavem, Knut ; Hansen, Tonya Moen. In: The European Journal of Health Economics. RePEc:spr:eujhec:v:24:y:2023:i:6:d:10.1007_s10198-022-01517-y.

Full description at Econpapers || Download paper

2023Using the EQ-5D-5L to investigate quality-of-life impacts of disease-modifying therapy policies for people with multiple sclerosis (MS) in New Zealand. (2023). Blizzard, Leigh C ; Palmer, Andrew J ; Carroll, William M ; Butzkueven, Helmut ; Simpson-Yap, Steve ; Kalincik, Tomas ; Mason, Deborah F ; Norman, Richard ; Taylor, Bruce V ; Campbell, Julie A ; Henson, Glen J ; Claflin, Suzi ; van der Mei, Ingrid. In: The European Journal of Health Economics. RePEc:spr:eujhec:v:24:y:2023:i:6:d:10.1007_s10198-022-01518-x.

Full description at Econpapers || Download 2023

Comparison of EQ-5D-5L and EORTC QLU-C10D utilities in gastric cancer patients. (2023). Wang, Pei ; Luo, Nan ; Zhao, Chun-Hua ; Zhu, Yan-Bo ; He, Jun-Yi ; Pan, Chen-Wei. In: The European Journal of Health Economics. RePEc:spr:eujhec:v:24:y:2023:i:6:d:10.1007_s10198-022-01523-0.

Full description at Econpapers || Download paper

2023Health technology assessment criteria as drivers of coverage with managed entry agreements: a case study of cancer medicines in four countries. (2023). Efthymiadou, Olina. In: The European Journal of Health Economics. RePEc:spr:eujhec:v:24:y:2023:i:7:d:10.1007_s10198-022-01526-x.

Full description at Econpapers || Download paper

2023What if 0 is not equal to 0? Inter-personal health utilities anchoring using the largest health gains. (2023). Jakubczyk, Micha. In: The European Journal of Health Economics. RePEc:spr:eujhec:v:24:y:2023:i:7:d:10.1007_s10198-022-01537-8.

Full description at Econpapers || Download paper

2023To what extent does the use of crosswalks instead of EQ-5D value sets impact reimbursement decisions?: a simulation study. (2023). Dongen, Johanna M ; Ben, Angela Jornada ; Bosmans, Judith E ; el Alili, Mohamed ; Finch, Aureliano Paolo. In: The European Journal of Health Economics. RePEc:spr:eujhec:v:24:y:2023:i:8:d:10.1007_s10198-022-01539-6.

Full description at Econpapers || Download paper

2023Developing an Australian utility value set for the Early Childhood Oral Health Impact Scale-4D (ECOHIS-4D) using a discrete choice experiment. (2023). Arrow, Peter ; Hettiarachchi, Ruvini M ; Kularatna, Sanjeewa ; Jamieson, Lisa ; Tonmukayawul, Utsana ; Norman, Richard ; Brain, David ; Carter, Hannah ; Senanayake, Sameera. In: The European Journal of Health Economics. RePEc:spr:eujhec:v:24:y:2023:i:8:d:10.1007_s10198-022-01542-x.

Full description at Econpapers || Download 2023

Systematic Review of the Effect of a One-Day Versus Seven-Day Recall Duration on Patient Reported Outcome Measures (PROMs). (2023). Mukuria, Clara ; Caruana, Julia M ; Peasgood, Tessa. In: The Patient: Patient-Centered Outcomes Research. RePEc:spr:patien:v:16:y:2023:i:3:d:10.1007_s40271-022-00611-w.

Full description at Econpapers || Download paper

2023Including Young Children in the Development and Testing of Patient Reported Outcome (PRO) Instruments: A Scoping Review of Children’s Involvement and Qualitative Methods. (2023). Carlton, Jill ; Gale, Victoria. In: The Patient: Patient-Centered Outcomes Research. RePEc:spr:patien:v:16:y:2023:i:5:d:10.1007_s40271-023-00637-8.

Full description at Econpapers || Download paper

2023The Egyptian EQ-5D-5L Extensive Pilot Study: Lessons Learned. (2023). Farid, Samar ; Stolk, Elly ; Finch, Aureliano ; Abbassi, Maggie ; Roudijk, Bram ; al Shabasy, Sahar. In: PharmacoEconomics. RePEc:spr:pharme:v:41:y:2023:i:3:d:10.1007_s40273-022-01208-9.

Full description at Econpapers || Download paper

2023Estimation of Health Utility Scores for Glycogen Storage Disease Type Ia. (2023). Lloyd, Andrew ; Freitas, Hayley ; Aggio, Daniel ; Kruger, Eliza. In: PharmacoEconomics - Open. RePEc:spr:pharmo:v:7:y:2023:i:4:d:10.1007_s41669-023-00397-z.

Full description at Econpapers || Download paper

2023Cost-Effectiveness Analysis of Siltuximab for Australian Public Investment in the Rare Condition Idiopathic Multicentric Castleman Disease. (2023). Rutherford, Carolyn ; Kirchmann, Matt ; Zibelnik, Natasa ; Wayi-Wayi, Grace ; Ademi, Zanfina ; Abrams, Keith R ; Shupo, Francis ; Makarounas-Kirchmann, Kelly. In: PharmacoEconomics - Open. RePEc:spr:pharmo:v:7:y:2023:i:5:d:10.1007_s41669-023-00426-x.

Full description at Econpapers || Download paper

2023What are Valid Weights for the Human Development Index? A Discrete Choice Experiment for the United Kingdom. (2023). Feeny, Simon ; Ombler, Franz ; Knowles, Stephen ; Hansen, Paul ; McGillivray, Mark. In: Social Indicators Research: An International and Interdisciplinary Journal for Quality-of-Life Measurement. RePEc:spr:soinre:v:165:y:2023:i:2:d:10.1007_s11205-022-03039-9.

Full description at Econpapers || Download paper

2023The effects of price transparency and debt collection policies on intentions to consume recommended health care: A randomized vignette experiment. (2023). Ko, Hansoo ; Epstein, Wendy Netter ; Robertson, Christopher T. In: Journal of Empirical Legal Studies. RePEc:wly:empleg:v:20:y:2023:i:4:p:941-960.

Full description at Econpapers || Download paper

Works by Nancy Devlin:

YearTitleTypeCited
1995Comment: Financing New Zealand’s Tertiary Education: How Much Subsidy? In: Agenda - A Journal of Policy Analysis and Reform.
[Full Text][Citation analysis]		article0
1994The effects of denturism: New Zealand dentists response to competition In: American Journal of Public Health.
[Citation analysis]		article0
2000The health state preferences and logistical inconsistencies of New Zealanders: a tale of two tariffs In: Working Papers.
[Full Text][Citation analysis]		paper6
2011Truly inefficient or providing better quality of care? Analysing the relationship between riskadjusted hospital costs and patients’ health outcomes In: Working Papers.
[Full Text][Citation analysis]		paper21
2013TRULY INEFFICIENT OR PROVIDING BETTER QUALITY OF CARE? ANALYSING THE RELATIONSHIP BETWEEN RISK?ADJUSTED HOSPITAL COSTS AND PATIENTS HEALTH OUTCOMES.(2013) In: Health Economics.
[Full Text][Citation analysis]
This paper has nother version. Agregated cites: 21		article
2012Analysing Hospital Variation in Health Outcome at the Level of EQ-5D Dimensions In: Working Papers.
[Full Text][Citation analysis]		paper1
2013Methods for the estimation of the NICE cost effectiveness threshold In: Working Papers.
[Full Text][Citation analysis]		paper49
2013The influence of cost-effectiveness and other factors on NICE decisions In: Working Papers.
[Full Text][Citation analysis]		paper25
2015The Influence of Cost?Effectiveness and Other Factors on Nice Decisions.(2015) In: Health Economics.
[Full Text][Citation analysis]
This paper has nother version. Agregated cites: 25		article
2015Local health care expenditure plans and their opportunity costs In: Health Policy.
[Full Text][Citation analysis]		article4
2020Do people with private health insurance attach a higher value to health than those without insurance? Results from an EQ-5D-5 L valuation study in Ireland In: Health Policy.
[Full Text][Citation analysis]		article1
2020The impact of price transparency on consumers and providers: A scoping review In: Health Policy.
[Full Text][Citation analysis]		article6
1996The cost-effectiveness of mammography screening: evidence from a microsimulation model for New Zealand In: Health Policy.
[Full Text][Citation analysis]		article8
2006Yes, No or Yes, but? Multinomial modelling of NICE decision-making In: Health Policy.
[Full Text][Citation analysis]		article7
2009Searching for cost effectiveness thresholds in the NHS In: Health Policy.
[Full Text][Citation analysis]		article26
2020A new tool for creating personal and social EQ-5D-5L value sets, including valuing ‘dead’ In: Social Science & Medicine.
[Full Text][Citation analysis]		article5
1999The cost-effectiveness of introducing a varicella vaccine to the New Zealand immunisation schedule In: Social Science & Medicine.
[Full Text][Citation analysis]		article3
2005Continuity through change: The rhetoric and reality of health reform in New Zealand In: Social Science & Medicine.
[Full Text][Citation analysis]		article9
2009A note on the nature of utility in time and health and implications for cost utility analysis In: Social Science & Medicine.
[Full Text][Citation analysis]		article6
2009Identifying the impact of government targets on waiting times in the NHS In: Health Care Management Science.
[Full Text][Citation analysis]		article32
2000Allocating Vote: Health — ‘Needs Assessment’ and an Economics-Based Approach In: Treasury Working Paper Series.
[Full Text][Citation analysis]		paper0
2016“New Age” Decision Making in HTA: Is It Applicable in Asia? In: Briefing.
[Full Text][Citation analysis]		paper0
2011Incorporating Multiple Criteria in HTA: Methods and Processes In: Monograph.
[Full Text][Citation analysis]		book22
2010Getting the Most out of PROMs: Putting Health Outcomes at the Heart of NHS Decision-Making In: Monograph.
[Full Text][Citation analysis]		book21
2002Cost-Effectiveness Thresholds: Economic and ethical issues In: Monograph.
[Full Text][Citation analysis]		book20
2004How Much Should We Spend on the NHS? In: Monograph.
[Full Text][Citation analysis]		book2
2012Time to tweak the TTO. But how? In: MPRA Paper.
[Full Text][Citation analysis]		paper1
2010Statistical Analysis of EQ-5D Profiles: Does the Use of Value Sets Bias Inference? In: Medical Decision Making.
[Full Text][Citation analysis]		article8
2010Protocols for Time Tradeoff Valuations of Health States Worse than Dead: A Literature Review In: Medical Decision Making.
[Full Text][Citation analysis]		article9
2013Hospital Variation in Patient-Reported Outcomes at the Level of EQ-5D Dimensions In: Medical Decision Making.
[Full Text][Citation analysis]		article10
2016What Determines the Shape of an EQ-5D Index Distribution? In: Medical Decision Making.
[Full Text][Citation analysis]		article2
2017EQ-5D and the EuroQol Group: Past, Present and Future In: Applied Health Economics and Health Policy.
[Full Text][Citation analysis]		article41
2017A Review of NICE Methods and Processes Across Health Technology Assessment Programmes: Why the Differences and What is the Impact? In: Applied Health Economics and Health Policy.
[Full Text][Citation analysis]		article4
2021Allocating Public Spending Efficiently: Is There a Need for a Better Mechanism to Inform Decisions in the UK and Elsewhere? In: Applied Health Economics and Health Policy.
[Full Text][Citation analysis]		article2
2021EQ-5D-5L Health-State Values for the Mexican Population In: Applied Health Economics and Health Policy.
[Full Text][Citation analysis]		article1
2022Supply-Side Cost-Effectiveness Thresholds: Questions for Evidence-Based Policy In: Applied Health Economics and Health Policy.
[Full Text][Citation analysis]		article0
2013The development of new research methods for the valuation of EQ-5D-5L In: The European Journal of Health Economics.
[Full Text][Citation analysis]		article9
2013The effects of lead time and visual aids in TTO valuation: a study of the EQ-VT framework In: The European Journal of Health Economics.
[Full Text][Citation analysis]		article3
2013Lead versus lag-time trade-off variants: does it make any difference? In: The European Journal of Health Economics.
[Full Text][Citation analysis]		article1
2013Time to tweak the TTO: results from a comparison of alternative specifications of the TTO In: The European Journal of Health Economics.
[Full Text][Citation analysis]		article3
2013One-to-one versus group setting for conducting computer-assisted TTO studies: findings from pilot studies in England and the Netherlands In: The European Journal of Health Economics.
[Full Text][Citation analysis]		article3
2017Head-to-head comparison of health-state values derived by a probabilistic choice model and scores on a visual analogue scale In: The European Journal of Health Economics.
[Full Text][Citation analysis]		article2
2018Valuing EQ-5D-5L health states ‘in context’ using a discrete choice experiment In: The European Journal of Health Economics.
[Full Text][Citation analysis]		article3
2019Impact of mapped EQ-5D utilities on cost-effectiveness analysis: in the case of dialysis treatments In: The European Journal of Health Economics.
[Full Text][Citation analysis]		article1
2019A new method for valuing health: directly eliciting personal utility functions In: The European Journal of Health Economics.
[Full Text][Citation analysis]		article6
2020An exploration of methods for obtaining 0 = dead anchors for latent scale EQ-5D-Y values In: The European Journal of Health Economics.
[Full Text][Citation analysis]		article3
2021What is the best approach to adopt for identifying the domains for a new measure of health, social care and carer-related quality of life to measure quality-adjusted life years? Application to the dev In: The European Journal of Health Economics.
[Full Text][Citation analysis]		article2
2005A ‘new and improved’ EQ-5D valuation questionnaire? In: The European Journal of Health Economics.
[Full Text][Citation analysis]		article2
2017Assessing Preference-Based Outcome Measures for Overactive Bladder: An Evaluation of Patient-Reported Outcome Data from the BESIDE Clinical Trial In: The Patient: Patient-Centered Outcomes Research.
[Full Text][Citation analysis]		article0
2021Giving a Voice to Marginalised Groups for Health Care Decision Making In: The Patient: Patient-Centered Outcomes Research.
[Full Text][Citation analysis]		article0
2010An Analysis of NICE’s ‘Restricted’ (or ‘Optimized’) Decisions In: PharmacoEconomics.
[Full Text][Citation analysis]		article2
2013Operationalizing Value-Based Pricing of Medicines In: PharmacoEconomics.
[Full Text][Citation analysis]		article12
2015A Checklist for Reporting Valuation Studies of Multi-Attribute Utility-Based Instruments (CREATE) In: PharmacoEconomics.
[Full Text][Citation analysis]		article5
2018Utility Values for Health States in Ireland: A Value Set for the EQ-5D-5L In: PharmacoEconomics.
[Full Text][Citation analysis]		article4
20183L, 5L, What the L? A NICE Conundrum In: PharmacoEconomics.
[Full Text][Citation analysis]		article2
2018Comparing the UK EQ-5D-3L and English EQ-5D-5L Value Sets In: PharmacoEconomics.
[Full Text][Citation analysis]		article6
2018Correction to: Comparing the UK EQ-5D-3L and English EQ-5D-5L Value Sets In: PharmacoEconomics.
[Full Text][Citation analysis]		article1
2018Correction to: 3L, 5L, What the L? A NICE Conundrum In: PharmacoEconomics.
[Full Text][Citation analysis]		article2
2020Review of Valuation Methods of Preference-Based Measures of Health for Economic Evaluation in Child and Adolescent Populations: Where are We Now and Where are We Going? In: PharmacoEconomics.
[Full Text][Citation analysis]		article8
2020International Valuation Protocol for the EQ-5D-Y-3L In: PharmacoEconomics.
[Full Text][Citation analysis]		article3
2022How are Child-Specific Utility Instruments Used in Decision Making in Australia? A Review of Pharmaceutical Benefits Advisory Committee Public Summary Documents In: PharmacoEconomics.
[Full Text][Citation analysis]		article0
2022A Comparison of PROPr and EQ-5D-5L Value Sets In: PharmacoEconomics.
[Full Text][Citation analysis]		article1
2022Systematic Review of Conceptual, Age, Measurement and Valuation Considerations for Generic Multidimensional Childhood Patient-Reported Outcome Measures In: PharmacoEconomics.
[Full Text][Citation analysis]		article1
2022Correction to: Systematic Review of Conceptual, Age, Measurement and Valuation Considerations for Generic Multidimensional Childhood Patient-Reported Outcome Measures In: PharmacoEconomics.
[Full Text][Citation analysis]		article1
2022Preference Elicitation Techniques Used in Valuing Children’s Health-Related Quality-of-Life: A Systematic Review In: PharmacoEconomics.
[Full Text][Citation analysis]		article0
2018Applying a Multicriteria Decision Analysis (MCDA) Approach to Elicit Stakeholders’ Preferences in Italy: The Case of Obinutuzumab for Rituximab-Refractory Indolent Non-Hodgkin Lymphoma (iNHL) In: PharmacoEconomics - Open.
[Full Text][Citation analysis]		article1
2019All Male Panels and Other Diversity Considerations for ISPOR In: PharmacoEconomics - Open.
[Full Text][Citation analysis]		article0
2001Health care spending and economic output: Granger causality In: Applied Economics Letters.
[Full Text][Citation analysis]		article57
2002The Purchasing of Health Care by Primary Care Organisations. An evaluation and Guide to Future Policy, by N. Mays, S. Wyke, G. Malbon, N. Goodwin. Open University Press, Buckingham and Philadelphia, 2 In: Health Economics.
[Full Text][Citation analysis]		article0
2003Logical inconsistencies in survey respondents health state valuations ? a methodological challenge for estimating social tariffs In: Health Economics.
[Full Text][Citation analysis]		article19
2004Does NICE have a cost?effectiveness threshold and what other factors influence its decisions? A binary choice analysis In: Health Economics.
[Full Text][Citation analysis]		article110
2004Getting Health Economics into Practice, Edited by David Kernick. Radcliffe Medical Press, Oxford, 2002. No. of pages: 358. ISBN 1?85775?575?8 In: Health Economics.
[Full Text][Citation analysis]		article0
2006A theoretical framework for TTO valuations of health In: Health Economics.
[Full Text][Citation analysis]		article6
2006Is there a case for using visual analogue scale valuations in cost?utility analysis? In: Health Economics.
[Full Text][Citation analysis]		article30
2007‘Is there a case for using visual analogue scale valuations in CUA? Yes there is a case, but what does it add to ordinal data?’ a rejoinder In: Health Economics.
[Full Text][Citation analysis]		article0
2010Patient?reported outcome measures in the NHS: new methods for analysing and reporting EQ?5D data In: Health Economics.
[Full Text][Citation analysis]		article9
2011A uniform time trade off method for states better and worse than dead: feasibility study of the ‘lead time’ approach In: Health Economics.
[Full Text][Citation analysis]		article30
2013A COMPARISON OF ALTERNATIVE VARIANTS OF THE LEAD AND LAG TIME TTO In: Health Economics.
[Full Text][Citation analysis]		article14
2015INTER?PROVIDER COMPARISON OF PATIENT?REPORTED OUTCOMES: DEVELOPING AN ADJUSTMENT TO ACCOUNT FOR DIFFERENCES IN PATIENT CASE MIX In: Health Economics.
[Full Text][Citation analysis]		article2
2018New methods for modelling EQ?5D?5L value sets: An application to English data In: Health Economics.
[Full Text][Citation analysis]		article10
2018Valuing health?related quality of life: An EQ?5D?5L value set for England In: Health Economics.
[Full Text][Citation analysis]		article31
2021Population norms for quality adjusted life years for the United States of America, China, the United Kingdom and Australia In: Health Economics.
[Full Text][Citation analysis]		article1

CitEc is a RePEc service, providing citation data for Economics since 2001. Sponsored by INOMICS. Last updated June, 27 2024. Contact: CitEc Team